What is ON Diagnostics?
O.N. Diagnostics specializes in Biomechanical Computed Tomography (BCT) analysis, a cutting-edge field focused on osteoporosis diagnostics. The company provides crucial measurements for bone mineral density and strength through its VirtuOst service. This innovative offering leverages existing CT scans of the hip or spine, eliminating the need for additional radiation exposure for patients. By delivering clinically impactful bone information, O.N. Diagnostics empowers physicians to enhance patient treatment strategies and better assess fracture risk. The company also engages with patients who have undergone relevant CT scans and collaborates with researchers to deepen the understanding of bone strength through clinical trials and studies.
How much funding has ON Diagnostics raised?
ON Diagnostics has raised a total of $143K across 1 funding round:
Debt
$143K
Debt (2021): $143K with participation from PPP
What's next for ON Diagnostics?
With a substantial late-stage funding context, ON Diagnostics is poised for significant scaling and market penetration. The recent strategic investment likely signals confidence from backers in the company's technology and its potential to disrupt the diagnostics sector. Future developments may include expanding the reach of the VirtuOst service, further refining BCT analysis techniques, and forging new research partnerships to solidify its position as a leader in bone health assessment.
See full ON Diagnostics company page
